# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 22.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-22.8-upside-potential/4121134791
- Published: 2023-12-01T11:53:16+00:00
- Author: Charlotte Edwards

**GE HealthCare Technologies Inc.** which can be found using ticker (GEHC) have 
now 11 analysts in total covering the stock. The consensus rating is pointing to‘
buy’. The range between the high target price and low target price is between $97.00
and $66.00 suggesting an average Analsyt target price of $83.14. Now with the previous
closing price of $67.71 this indicates there is a potential upside of 22.8%. The
day 50 moving average is $68.10 and the 200 moving average now moves to $74.53. 
The company has a market capitalization of 31.17B. The stock price for the company
is currently is currently $68.46 USD

 The potential market cap would be $38,268,141,886 based on the market consensus.

The company has a dividend yield of 0.77%. Other points of data to note are a P/
E ratio of 20.31, revenue per share of $42.36 and a 6.17% return on assets.

GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics,
and digital solutions company. The Company develops, manufactures, and markets a
portfolio of products, services, and complementary digital solutions used in the
diagnosis, treatment, and monitoring of patients. The Company’s segments include
Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The 
Imaging segment includes scanning devices, clinical applications, service capabilities
and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment,
and monitoring of certain diseases. The Patient Care Solutions segment includes 
medical devices, services, consumable products, services, and digital solutions.
The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the
global radiology and nuclear medicine industry.

Share on: